{"schema_version":"secwatch.filing_event.v1","accession":"0001662774-24-000013","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.151143+00:00","generated_at":"2026-05-30T00:30:35.079665+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Quince Therapeutics regains Nasdaq minimum bid price compliance; delisting risk removed","bullets":["On Nov 12, 2024, Nasdaq confirmed Quince regained compliance with $1.00 minimum bid price rule.","Compliance achieved after closing bid price stayed at or above $1.00 for 10 consecutive business days (Oct 29–Nov 11, 2024).","This resolves the non-compliance notice received June 20, 2024, and the matter is closed.","The company was facing potential delisting from Nasdaq Global Select Market if not compliant by Dec 17, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001662774-24-000013","json":"https://secwatch.observer/filing/0001662774-24-000013.json","markdown":"https://secwatch.observer/filing/0001662774-24-000013.md","text":"https://secwatch.observer/filing/0001662774-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/0001662774-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000166277424000013/qncx-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:30:35.079665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}